Gene therapy's promise and hope for the blind: ONCE CEO

8:33 AM ET Tue, 19 May 2015

Jeffrey Marrazzo, Spark Therapeutics CEO, and Dr. Jean Bennett, Spark Therapeutics advisor, discuss how advances in gene therapy are changing the way rare diseases are treated. And Gordon Gund, Gund Investment Corp. CEO, weighs in.